Roche’s BTK inhibitor may have reached ‘holy grail’ of brain penetration in phase 2 MS trial – FierceBiotech October 13, 2023
Carl June, Vertex execs and Parkinson’s scientists win Breakthrough prizes – FierceBiotech September 15, 2023
Sanofi taps Scribe for in vivo partnership worth more than $1.2B biobucks aimed at sickle cell and beyond – FierceBiotech July 17, 2023
J&J capitalizes on Nanobiotix cash crunch to capture late-phase cancer candidate for $30M upfront – FierceBiotech July 10, 2023
Lilly’s next obesity drug just cut an average of 58 pounds—prompting an all-out phase 3 blitz – FierceBiotech June 27, 2023
AstraZeneca pays $85M to Quell Type 1 diabetes with ‘one and done’ cell therapy – FierceBiotech June 9, 2023